Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Sands Capital Alternatives, LLC
Form 13F · Q2 2026

Sands Capital Alternatives, LLC

CIK 1846444Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$614M
Reported book value
24
Positions
12
Quarters on record
Top 50
Positions

Sands Capital Alternatives, LLC — holdings

Top 24 positions of 24, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ALMR Alamar Biosciences Inc4.2M—$115M18.7%
2NU Nu Hldgs Ltd7.1M+8.5%$95M15.4%
3KVYO Klaviyo Inc3.9M+7.6%$59M9.7%
4BBNX Beta Bionics Inc3.7M+0.0%$58M9.5%
5SGP Spyglass Pharma Inc2.5M+0.0%$56M9.1%
6IKT Inhibikase Therapeutics Inc13.0M+0.0%$26M4.3%
7DASH Doordash Inc127,562+14.7%$24M3.8%
8CPNG Coupang Inc1.3M+31.3%$23M3.8%
9DDOG Datadog Inc80,851−5.8%$21M3.4%
10BIOA Bioage Labs Inc786,353+0.0%$19M3.1%
11TXG 10X Genomics Inc481,770+0.0%$18M3.0%
12IOT Samsara Inc515,658−8.0%$17M2.7%
13ODTX Odyssey Therapeutics Inc875,000—$16M2.7%
14TOST Toast Inc364,879+21.0%$10M1.7%
15ABOS Acumen Pharmaceuticals Inc3.7M+0.0%$10M1.6%
16TTAN Servicetitan Inc108,545+20.8%$8M1.3%
17CBRS Cerebras Systems Inc32,825—$7M1.2%
18SNOW Snowflake Inc24,498+21.0%$6M1.0%
19MNDY Monday Com Ltd81,982+20.8%$6M1.0%
20TARS Tarsus Pharmaceuticals Inc85,000+0.0%$5M0.9%
21TSHA Taysha Gene Therapies Inc724,873+0.0%$5M0.8%
22CADL Candel Therapeutics Inc405,837+0.0%$4M0.7%
23ACRV Acrivon Therapeutics Inc2.3M+7.9%$4M0.7%
24FIG Figma Inc22,165+21.2%$400,9650.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.